Archive for June, 2006

Panel of Experts to Review Importance of Introgen Therapeutics' … - Yahoo! News (press release)

Panel of Experts to Review Importance of Introgen Therapeutics' …Yahoo! News (press release) - 6 hours ago… In addition, Introgen will discuss the successful use of ADVEXIN for Li- Fraumeni Syndrome cancer, an inherited form of malignancy characterized by the loss of …

Read full story

Comments

New Clinical Data For ADVEXIN Recurrent Head And Neck Cancer … - Medical News Today (press release)

New Clinical Data For ADVEXIN Recurrent Head And Neck Cancer …Medical News Today (press release), UK - May 27, 2006… Introgen recently announced it will provide ADVEXIN p53 therapy for compassionate use to treat qualified cancer patients suffering from Li- Fraumeni Syndrome. …

Read full story

Comments

Current Controversies in Diagnosis and Staging of Lung Cancer - Medscape (subscription)

Current Controversies in Diagnosis and Staging of Lung CancerMedscape (subscription) - May 25, 2006… These are nodular type II pneumocyte hyperplasia associated with tuberous sclerosis [26] and AAH in the setting of Li-Fraumeni syndrome. …

Read full story

Comments

Advexin useful in Li-Fraumeni syndrome - United Press International

Advexin useful in Li-Fraumeni syndromeUnited Press International - Jun 2, 2006WASHINGTON, June 2 (UPI) — Prelminary results in one patient show that Introgen's Advexin p53 therapy (Introgen may work for Li-Fraumeni syndrome (LFS). …

Read full story

Comments

The family Battle - St. Petersburg Times

St. Petersburg TimesThe family BattleSt. Petersburg Times, FL - Jun 10, 2006… Or something with a truly strange name: Li-Fraumeni Syndrome? Craesha Gordon, 8, of Clearwater waits to see the doctor at H. Lee Moffitt Cancer Center. …

Read full story

Comments

Advexin Useful in Li-Fraumeni Syndrome - International News Service

Advexin Useful in Li-Fraumeni SyndromeInternational News Service, Australia - Jun 2, 2006Prelminary results in one patient show that Introgen's Advexin p53 therapy (Introgen may work for Li-Fraumeni syndrome (LFS). LFS …

Read full story

Comments

Positive Data for Introgen's Targeted Cancer Therapy - International News Service

Positive Data for Introgen's Targeted Cancer TherapyInternational News Service, Australia - Jun 5, 2006… targeted molecular therapy Advexin has demonstrated beneficial effects and key markers of clinical activity in a cancer patient with Li-Fraumeni syndrome. …

Read full story

Comments

Introgen's Advexin p53 Therapy Demonstrates Clinical Benefit in … - DG News

Introgen's Advexin p53 Therapy Demonstrates Clinical Benefit in …DG News - Jun 2, 2006presented important data describing the beneficial effects and key markers of clinical activity in a cancer patient with Li-Fraumeni Syndrome (LFS), a genetic …

Read full story

Comments

Introgen Therapeutics Says ADVEXIN P53 Therapy Beneficial In … - Trading Markets

Introgen Therapeutics Says ADVEXIN P53 Therapy Beneficial In …Trading Markets, CA - Jun 2, 2006… a bio-pharmaceutical company, reported beneficial effects and key markers of clinical activity of ADVEXIN in a cancer patient with Li-Fraumeni Syndrome. …

Read full story

Comments

Introgen Study Shows Advexin Benefit - MSN Money

Introgen Study Shows Advexin BenefitMSN Money - Jun 2, 2006A study showed that Li-Fraumeni Syndrome patients given Advexin responded to the treatment and showed an improvement in tumor-related symptoms as verified by …

Read full story

Comments

Central Texas Digest - Austin American-Statesman (subscription)

Central Texas DigestAustin American-Statesman (subscription), TX - Jun 2, 2006… A study showed that Li-Fraumeni Syndrome patients given Advexin responded to the treatment and showed an improvement in tumor-related symptoms as verified by …

Read full story

Comments

Introgen Therapeutics Says ADVEXIN P53 Therapy Demonstrates … - Trading Markets

Introgen Therapeutics Says ADVEXIN P53 Therapy Demonstrates …Trading Markets, CA - Jun 2, 2006… PowerRating) revealed results of data describing the beneficial effects and key markers of clinical activity in a cancer patient with Li-Fraumeni Syndrome. …

Read full story

Comments

Introgen To Announce Clinical Results Of ADVEXIN P53 Cancer … - Trading Markets

Introgen To Announce Clinical Results Of ADVEXIN P53 Cancer …Trading Markets, CA - May 26, 2006… recently announced that it would provide ADVEXIN p53 therapy for compassionate use to treat qualified cancer patients suffering from Li- Fraumeni Syndrome. …

Read full story

Comments

· « Previous entries